Table 1 Description of quantitative measures assessed by group, and the results of the comparative tests
Varible | Treatment | Mean | SD | Median | Minimum | Maxumum | N | p |
|---|---|---|---|---|---|---|---|---|
KPS (%) | SRS | 90.00 | 5.08 | 90 | 80 | 100 | 32 | 0.457 |
SRT | 89.12 | 5.44 | 90 | 80 | 100 | 57 | ||
Total | 89.44 | 5.30 | 90 | 80 | 100 | 89 | ||
Duration of symptms (months) | SRS | 15.74 | 23.03 | 9 | 3 | 120 | 32 | 0.208* |
SRT | 19.04 | 24.62 | 12 | 1 | 156 | 57 | ||
Total | 17.86 | 23.98 | 11 | 1 | 156 | 89 | ||
Age (year) | SRS | 61.03 | 16.38 | 55 | 39 | 107 | 32 | 0.278 |
SRT | 57.12 | 15.87 | 56 | 7 | 85 | 57 | ||
Total | 58.50 | 16.07 | 56 | 7 | 107 | 89 | ||
Tumor volume (cc) | SRS | 8.25 | 10.88 | 6 | 1.5 | 58.7 | 32 | <0.001 |
SRT | 25.39 | 9.91 | 23.6 | 10.9 | 48 | 57 | ||
Total | 19.23 | 13.14 | 18.2 | 1.5 | 58.7 | 89 |